Form 8-K - Current report:
SEC Accession No. 0001193125-25-168148
Filing Date
2025-07-29
Accepted
2025-07-29 17:28:26
Documents
16
Period of Report
2025-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d945712d8k.htm   iXBRL 8-K 28901
2 EX-99.1 d945712dex991.htm EX-99.1 78039
7 GRAPHIC g945712dsp1.jpg GRAPHIC 27878
8 GRAPHIC g945712dsp2.jpg GRAPHIC 19573
  Complete submission text file 0001193125-25-168148.txt   333441

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250729.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250729_def.xml EX-101.DEF 13867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250729_lab.xml EX-101.LAB 22898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250729_pre.xml EX-101.PRE 14705
18 EXTRACTED XBRL INSTANCE DOCUMENT d945712d8k_htm.xml XML 5888
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 251163157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)